Collaborative Research in Critical Care Medicine: A Way Forward to High-impact Publications from India
Natesh Prabu Ravisankar, Mohan Gurjar
Keywords :
Critical care, Publications, Quality, Randomized controlled trial, Research
Citation Information :
Ravisankar NP, Gurjar M. Collaborative Research in Critical Care Medicine: A Way Forward to High-impact Publications from India. Indian J Crit Care Med 2023; 27 (12):869-870.
Varghese GM, Dayanand D, Gunasekaran K, Kundu D, Wyawahare M, Sharma N, et al. Intravenous doxycycline, azithromycin, or both for severe scrub typhus. N Engl J Med 2023;388(9):792–803. DOI: 10.1056/NEJMoa2208449.
John J, Bavdekar A, Rongsen-Chandola T, Dutta S, Gupta M, Kanungo S, et al. Burden of typhoid and paratyphoid fever in India. N Engl J Med 2023;388(16):1491–1500. DOI: 10.1056/NEJMoa2209449.
Soin AS, Kumar K, Choudhary NS, Sharma P, Mehta Y, Kataria S, et al. Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): An open-label, multicentre, randomised, controlled, phase 3 trial. Lancet Respir Med 2021;9(5):511–521. DOI: 10.1016/S2213-2600(21)00081-3.
Mathur P, Malpiedi P, Walia K, Srikantiah P, Gupta S, Lohiya A, et al. Health-care-associated bloodstream and urinary tract infections in a network of hospitals in India: A multicentre, hospital-based, prospective surveillance study. Lancet Glob Health 2022;10(9): e1317–e1325. DOI: 10.1016/S2214-109X(22)00274-1.
Raasveld SJ, de Bruin S, Reuland MC, van den Oord C, Schenk J, Aubron C, et al. Red blood cell transfusion in the Intensive Care Unit. JAMA 2023:e2320737. DOI: 10.1001/jama.2023.20737.
COVID STEROID 2 Trial Group, Munch MW, Myatra SN, Vijayaraghavan BKT, Saseedharan S, Benfield T, et al. Effect of 12 mg vs 6 mg of Dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: The COVID Steroid 2 randomized trial. JAMA 2021;326(18):1807–1817. DOI: 10.1001/jama.2021.18295.
Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries. JAMA 2021;325(12):1164–1172. DOI: 10.1001/jama.2021.1727.
Li A, Ling L, Qin H, Arabi YM, Myatra SN, Egi M, et al. Epidemiology, management, and outcomes of sepsis in ICUs among countries of differing National wealth across Asia. Am J Respir Crit Care Med 2022;206(9):1107–1116. DOI: 10.1164/rccm.202112-2743OC.
Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: The EUROBACT-2 international cohort study. Intensive Care Med 2023;49(2):178–190. DOI: 10.1007/s00134-022-06944-2.
Phua J, Lim CM, Faruq MO, Nafees KMK, Du B, Gomersall CD, et al. The story of critical care in Asia: A narrative review. J intensive care 2021;9:60. DOI: https://doi.org/10.1186/s40560-021-00574-4.
Divatia JV, Mehta Y, Govil D, Zirpe K, Amin PR, Ramakrishnan N, et al. Intensive care in India in 2018–2019: The Second Indian intensive care case mix and practice patterns study. Indian J Crit Care Med 2021;25(10):1093–1107. DOI: 10.5005/jp-journals-10071-23965.
Vijayaraghavan BKT, Venkataraman R, Ramanathan Y, Margabandhu S, Jayakumar D, Ramachandran P, et al. A pilot feasibility randomized controlled trial of intravenous vitamin C in adults with sepsis in the intensive care unit: The lessening organ dysfunction with vitamin C-India (LOVIT-India) trial. Indian J Crit Care Med 2023;27(12):910–916.
